Bristol-Myers Squibb Canada Co. v. Mylan Pharmaceuticals ULC et al., (2012) 419 F.T.R. 55 (FC)
Linked as:
Extract
Bristol-Myers Squibb Canada Co. v. Mylan Pharmaceuticals ULC et al., (2012) 419 F.T.R. 55 (FC)
No longer available (Autolink)
See the full content of this document
This document cites
- F.H. v. McDougall, (2008) 260 B.C.A.C. 74 (SCC)
- Eli Lilly Canada Inc. v. Apotex Inc. et al., 2009 FC 320
- Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
- Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 414 F.T.R. 56 (FC)
- Halford v. Seed Hawk Inc., (2006) 353 N.R. 60 (FCA)